MedEquities Realty Trust Inc (MRT) Receives $12.80 Average Target Price from Brokerages

Shares of MedEquities Realty Trust Inc (NYSE:MRT) have been assigned an average rating of “Buy” from the eight research firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $12.80.

Several equities analysts have commented on MRT shares. Cantor Fitzgerald started coverage on MedEquities Realty Trust in a report on Thursday, August 31st. They set an “overweight” rating and a $14.00 price target on the stock. ValuEngine upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating in a report on Friday, December 1st. KeyCorp reiterated a “buy” rating and set a $13.00 price target on shares of MedEquities Realty Trust in a report on Friday, August 25th. Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 price target on the stock in a report on Wednesday, November 15th. Finally, B. Riley reiterated a “buy” rating on shares of MedEquities Realty Trust in a report on Wednesday, November 8th.

Shares of MedEquities Realty Trust (NYSE MRT) traded up $0.34 during mid-day trading on Monday, reaching $11.43. The company’s stock had a trading volume of 2,890,000 shares, compared to its average volume of 250,861. MedEquities Realty Trust has a one year low of $10.06 and a one year high of $13.06. The firm has a market capitalization of $362.97 and a P/E ratio of 10.07.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 29th. Stockholders of record on Wednesday, November 15th were given a $0.21 dividend. The ex-dividend date of this dividend was Tuesday, November 14th. This represents a $0.84 annualized dividend and a dividend yield of 7.35%. MedEquities Realty Trust’s dividend payout ratio is 215.38%.

In other MedEquities Realty Trust news, Director Randy L. Churchey acquired 5,300 shares of MedEquities Realty Trust stock in a transaction dated Monday, November 20th. The stock was bought at an average cost of $10.87 per share, with a total value of $57,611.00. Following the completion of the transaction, the director now owns 46,776 shares of the company’s stock, valued at $508,455.12. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John W. Mcroberts acquired 18,000 shares of MedEquities Realty Trust stock in a transaction dated Friday, November 17th. The stock was acquired at an average cost of $10.74 per share, with a total value of $193,320.00. The disclosure for this purchase can be found here. Insiders bought 23,600 shares of company stock valued at $254,129 over the last three months. 2.50% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. JPMorgan Chase & Co. bought a new position in MedEquities Realty Trust in the third quarter worth $118,000. Raymond James Financial Services Advisors Inc. bought a new position in MedEquities Realty Trust in the second quarter worth $154,000. Acadian Asset Management LLC bought a new position in MedEquities Realty Trust in the second quarter worth $175,000. Alliancebernstein L.P. bought a new position in MedEquities Realty Trust in the second quarter worth $175,000. Finally, Cubist Systematic Strategies LLC bought a new position in MedEquities Realty Trust in the third quarter worth $177,000. 93.19% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This story was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at https://www.com-unik.info/2017/12/16/medequities-realty-trust-inc-mrt-receives-12-80-average-target-price-from-brokerages.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

What are top analysts saying about MedEquities Realty Trust? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MedEquities Realty Trust and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit